publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
origin
research
copd
journalpublicationschestnetorg
chest
august
tudi
copd
use
selfreport
possibl
copd
exacerb
detect
onethird
onehalf
exacerb
occur
particip
use
paperbas
data
record
studi
respiratori
diseas
often
falsifi
data
likelihood
occur
increas
length
studi
one
random
trial
electron
symptom
record
ing
vs
monitor
paperbas
record
actual
complianc
electron
group
wherea
fabric
complianc
paperbas
record
copd
exacerb
requir
hospit
treatment
frequent
winter
peak
copd
hospit
mortal
occur
england
yearend
observ
center
christma
period
unit
kingdom
canada
sweden
toward
revolut
copd
health
torch
studi
highest
rate
copd
exacerb
northern
hemispher
particip
occur
decemb
nexthighest
januari
furthermor
children
present
gener
practition
england
wale
acut
bronchiti
hospit
respiratori
diseas
increas
immedi
christma
period
preced
peak
adult
period
school
attend
high
level
respiratori
viru
detect
children
shown
coincid
background
paperbas
diari
selfreport
symptom
worsen
copd
may
lead
underdetect
exacerb
epidemiolog
copd
exacerb
exhibit
season
pattern
peak
yearend
examin
whether
use
blackberrybas
daili
symptom
diari
would
detect
exacerb
enabl
character
season
differ
among
decemb
particip
transmit
daili
symptom
diari
use
blackberri
alert
trigger
symptom
chang
miss
diari
transmiss
medic
care
respiratori
problem
occur
particip
encount
initi
copd
exacerb
suspect
particip
use
blackberri
report
return
normal
breath
result
particip
transmit
possibl
daili
diari
copd
exacerb
meet
anthonisen
criteria
detect
exacerb
patient
hospit
andor
order
prednison
antibiot
respiratori
virus
detect
exacerb
coincid
respiratori
viral
infect
averag
day
without
averag
day
p
differ
anthonisen
score
respiratori
symptom
score
exacerb
normal
breath
return
show
differ
exacerb
frequent
christma
period
rest
year
frequent
rest
winter
alon
conclus
smartphonebas
collect
copd
symptom
diari
enabl
nearcomplet
identifi
cation
exacerb
incept
exacerb
rate
christma
season
reach
level
necessit
chang
diseas
manag
chest
research
ethic
board
st
joseph
healthcar
hamilton
inclus
criteria
age
year
abil
commun
english
copd
diagnosi
meet
criteria
gold
global
initi
chronic
obstruct
lung
diseas
stage
iv
classifi
cation
current
exsmok
minimum
packyear
exposur
previou
demonstr
revers
fev
increas
fev
ml
inhal
g
salbutamol
willing
provid
inform
consent
resid
noninstitut
domicil
without
current
plan
transfer
institut
care
exclus
criteria
signifi
cant
comorbid
would
interfer
particip
abil
complet
studi
protocol
includ
use
blackberri
plan
away
signifi
cant
part
studi
histori
asthma
season
allerg
rhiniti
particip
meet
inclus
criteria
underw
baselin
assess
includ
clinic
histori
spirometri
bode
bmi
airfl
ow
obstruct
dyspnea
exercis
capac
index
calcul
complet
st
georg
respiratori
questionnair
collect
sampl
sputum
nasal
brush
virolog
test
blood
measur
creactiv
protein
titer
studi
particip
medic
care
remain
physician
enrol
particip
provid
train
use
model
blackberri
smartphon
blackberri
control
monitor
central
function
blackberri
need
studi
disabl
particip
alert
new
daili
diari
eappendix
deliv
blackberri
daili
question
answer
diari
encrypt
transmit
wirelessli
data
server
flag
program
alert
staff
one
symptom
move
two
level
sever
given
day
symptom
reach
worst
level
given
day
particip
report
healthsystem
encount
respiratori
problem
report
symptom
respiratori
infect
transmit
two
sequenti
daili
diari
request
contact
staff
particip
whose
diari
met
one
aforement
criteria
contact
studi
nurs
ask
use
lay
terminolog
confi
rm
whether
thought
breathless
wors
usual
daytoday
variat
increas
sputum
volum
andor
sputum
purul
andor
medic
attent
sought
sought
breath
problem
andor
respiratori
infect
probabl
new
possibl
exacerb
confi
rmed
meet
studi
nurs
particip
home
schedul
soon
possibl
particip
underw
postbronchodil
spirometri
spiropro
btl
inc
specimen
sputum
nasal
brush
nostril
taken
virolog
analysi
particip
notifi
ed
three
supplementari
question
eappendix
would
appear
daili
diari
determin
prednison
antibiot
taken
breath
return
normal
given
day
occur
supplementari
question
remov
remot
command
daili
diari
hospit
staff
met
particip
soon
medic
accept
approv
attend
physician
particip
continu
diari
submiss
hospit
sever
copd
exacerb
anthonisen
criteria
assess
copd
nurs
exacerb
length
defi
ned
higher
rate
hospit
copd
suggest
school
attend
foster
transmiss
respiratori
infect
children
adult
respiratori
viral
infect
rvi
coincid
substanti
proport
copd
exacerb
previou
studi
use
fax
daili
symptom
diari
monitor
patient
copd
singl
winter
period
exacerb
meet
anthonisen
criteria
one
detect
occurr
howev
faxbas
system
requir
high
level
patient
support
staff
data
transmiss
could
occur
singl
locat
primari
object
studi
determin
whether
exacerb
cohort
patient
copd
could
detect
use
secur
devic
could
use
anywher
would
well
accept
patient
would
requir
modest
staff
support
enabl
collect
supplementari
inform
exacerb
occur
secondari
object
confi
rm
previou
observ
copd
exacerb
frequent
christma
period
time
year
prospect
observ
studi
cohort
patient
copd
mix
diseas
sever
maximum
period
month
studi
conduct
decemb
april
studi
particip
recruit
clinic
respiratori
specialist
refer
primarycar
physician
region
hamilton
canada
studi
approv
fisher
scientifi
c
inc
nucleic
acid
extract
l
homogen
sputum
use
magna
pure
lc
system
hoffmanla
roch
inc
follow
manufactur
instruct
two
hundr
microlit
nasal
phosphatebuff
salin
extract
without
manipul
use
magna
pure
dna
instrument
viral
na
small
volum
extract
kit
hoffmanla
roch
inc
elut
volum
set
l
virolog
test
undertaken
use
realtim
polymeras
chain
reaction
panel
viral
target
infl
uenza
b
respiratori
syncyti
viru
parainfl
uenza
viru
type
adenoviru
human
rhinoviru
four
current
circul
human
coronaviru
type
human
metapneumoviru
bocaviru
realtim
polymeras
chain
reaction
cellular
gene
transcript
rnasep
use
measur
specimen
qualiti
extract
control
rna
phage
ad
specimen
extract
potenti
particip
identifi
ed
chart
review
declin
elig
assess
inelig
see
eappendix
detail
recruit
one
particip
withdrew
assess
begin
studi
fortynin
particip
provid
data
decemb
novemb
one
die
period
studi
extend
decemb
april
fortysix
origin
particip
continu
extens
period
one
hundr
fortyon
new
candid
identifi
ed
declin
elig
assess
inelig
eappendix
second
studi
period
fi
particip
die
seventyon
peopl
complet
studi
extens
demograph
clinic
period
date
exacerb
confi
rmed
date
particip
report
return
normal
breath
prior
studi
defi
ned
christma
copd
epidem
period
decemb
januari
includ
period
frequent
social
activ
christma
decemb
orthodox
christma
januari
ontario
signifi
cant
popul
orthodox
christian
heritag
arbitrari
period
follow
relat
symptom
episod
develop
rest
winter
defi
ned
januari
april
third
studi
period
may
novemb
assess
complianc
complet
daili
diari
questionnair
detect
copd
exacerb
descript
secondari
analys
compar
annual
rate
copd
exacerb
proport
exacerb
coincid
rvi
two
christma
period
two
restofwint
period
period
may
novemb
differ
exacerb
rate
period
test
use
x
test
observ
rate
exacerbationsparticipantyear
compar
number
expect
across
time
period
christma
restofwint
period
exacerb
length
anthonisen
score
without
presenc
rvi
examin
use
student
test
determin
whether
differ
among
symptom
level
exacerb
daili
diari
data
question
eappendix
analyz
repeatedmeasur
analysi
varianc
two
factor
beforeduringaft
question
analysi
repeat
score
determin
symptom
level
return
baselin
exacerb
sputum
sampl
homogen
shake
min
addit
equal
volum
sputasol
thermo
tabl
subject
characterist
gold
n
ii
n
gold
iii
n
iv
n
cours
prednison
exacerb
gold
ii
former
particip
exacerb
also
longer
averag
howev
experienc
minim
reduct
baselin
percentag
predict
fev
wherea
gold
ii
averag
drop
mean
averag
symptom
score
across
question
preexacerb
postexacerb
differ
signifi
cant
f
p
rate
exacerb
christma
period
higher
two
period
rest
winter
rest
year
differ
exacerb
rate
christma
period
rest
year
signifi
cant
x
p
differ
exacerb
rate
christma
period
rest
winter
alon
signifi
cant
x
signfi
cant
characterist
exacerb
three
studi
period
shown
tabl
baselin
nasalfl
uid
sampl
obtain
particip
sputum
specimen
characterist
studi
particip
shown
tabl
particip
transmit
possibl
daili
diari
particip
complet
diari
inpati
hospit
day
one
hundr
ninetytwo
particip
encount
initi
possibl
copd
exacerb
event
meet
anthonisen
criteria
type
type
type
remain
event
particip
experienc
worsen
dyspnea
antibiot
order
physician
visit
breath
problem
occur
exacerb
tabl
overal
rate
exacerb
observ
exacerb
particip
hospit
andor
began
oral
prednison
antibiot
median
length
exacerb
particip
report
return
normal
breath
ing
end
studi
interquartil
rang
day
particip
gold
iii
iv
categori
twice
like
prescrib
degre
may
possibl
multicent
studi
howev
blackberrybas
system
use
copd
studi
includ
larg
multicountri
clinic
trial
complianc
particip
report
breath
return
normal
exacerb
use
supplementari
blackberri
diari
question
analysi
diari
symptom
data
establish
selfassess
accur
suggest
assess
respiratori
health
patient
copd
percept
christma
period
defi
ned
involv
elev
exacerb
risk
patient
copd
signifi
cant
compar
rest
winter
sinc
studi
complet
two
report
season
pattern
copd
exacerb
major
clinic
trial
torch
prevent
exacerb
tiotropium
copd
poetcopd
publish
northern
hemispher
exacerb
occur
frequent
decemb
januari
origin
character
christma
peak
copd
exacerb
examin
data
ed
present
copd
ontario
canada
period
summari
data
provid
e
tabl
everi
year
last
week
year
christma
day
new
year
eve
highest
number
event
exist
specifi
c
christma
effect
oppos
elev
risk
broader
period
demonstr
larg
administr
data
set
suggest
prepar
patient
copd
risk
one
baselin
nasalfl
uid
specimen
seven
baselin
sputum
specimen
viru
posit
rhinoviru
exacerb
nasalfl
uid
sampl
obtain
confi
rmed
copd
exacerb
sputum
sampl
respiratori
virus
present
copd
exacerb
tabl
fortyfi
nasal
specimen
sputum
specimen
posit
one
virus
exacerb
coincid
rvi
return
normal
breath
occur
end
studi
last
averag
day
compar
day
without
rvi
p
fig
anthonisen
score
episod
viru
present
absent
sd
sd
respect
p
shown
extend
period
time
patient
copd
provid
daili
respiratoryhealth
data
nearperfect
complianc
use
blackberri
devic
interpret
fi
nding
one
must
keep
mind
possibl
studi
popul
bias
toward
particip
confi
dent
use
electron
devic
studi
team
also
assidu
maintain
oversight
particip
tabl
nasalfl
uid
sputum
virus
differ
found
one
type
sampl
confi
rming
role
rvi
copd
symptom
exacerb
includ
examin
nasal
fl
uid
sputum
viru
detect
specimen
taken
recruit
rhinoviru
found
one
nasalfl
uid
sampl
winter
whole
christma
season
specifi
calli
would
prudent
detect
one
respiratori
virus
exacerb
virus
like
detect
sputum
nasal
fl
uid
report
previous
major
case
addit
combin
virus
detect
fi
exacerb
two
coronaviru
present
nasal
fl
uid
rhinoviru
sputum
one
respiratori
syncyti
viru
present
nasal
fl
uid
human
metapneumoviru
sputum
one
adenoviru
present
nasal
fl
uid
human
rhinoviru
sputum
one
adenoviru
coronaviru
present
sputum
seven
sputum
sampl
recruit
occur
fall
period
rhinoviru
common
conclud
posit
particip
cold
time
exacerb
coincid
rvi
took
longer
resolv
without
rvi
consist
fi
nding
studi
sever
base
anthonisen
score
conclus
use
blackberrybas
technolog
permit
earli
complet
detect
copd
exacerb
technolog
may
foster
adopt
patientreport
outcom
symptombas
measur
clinic
studi
facilit
earli
detect
deterior
highrisk
patient
copd
regular
clinic
practic
howev
occur
effect
approach
must
evalu
full
spectrum
patient
copd
author
contribut
mr
johnston
respons
integr
manuscript
studi
data
mr
johnston
contribut
lead
studi
design
team
cosupervis
conduct
studi
draft
review
manuscript
ms
lambert
contribut
lead
studi
oper
team
patient
assess
manag
patient
particip
write
review
manuscript
ms
hussack
contribut
patient
assess
manag
patient
particip
write
review
manuscript
dr
gerhardsson
de
verdier
contribut
intellectu
guidanc
throughout
studi
incept
design
conduct
write
review
manuscript
dr
higenbottam
contribut
assess
studi
event
audit
patient
data
guidanc
assist
studi
design
result
interpret
throughout
write
review
manuscript
mr
lewi
contribut
guidanc
assist
studi
design
result
interpret
throughout
write
review
manuscript
dr
newbold
contribut
guidanc
assist
studi
design
result
interpret
throughout
write
review
manuscript
mr
jenkin
contribut
design
conduct
statist
analys
write
review
manuscript
dr
norman
contribut
design
conduct
statist
analys
write
review
manuscript
dr
coyl
contribut
conduct
virolog
test
interpret
result
write
review
manuscript
dr
mcivor
contribut
clinic
assess
studi
patient
lead
patient
recruit
cosupervis
conduct
studi
write
review
manuscript
financialnonfi
nancial
disclosur
author
report
chest
follow
confl
ict
interest
mr
johnston
receiv
research
fund
andor
honoraria
merck
canada
inc
glaxosmithklin
canada
astrazeneca
also
own
share
glaxosmithklin
dr
mcivor
receiv
honoraria
educ
event
advisori
board
phase
clinic
trial
pharmaceut
compani
includ
astrazeneca
boehringeringelheim
gmbh
takeda
pharmaceut
compani
limit
pfi
zer
inc
merck
co
inc
glaxosmithklin
dr
higenbottam
employ
chiesi
farmaceutici
spa
within
past
year
dr
gerhardsson
de
verdier
newbold
messr
lewi
jenkin
employ
astrazeneca
share
compani
mss
lambert
hussack
dr
norman
coyl
report
potenti
confl
ict
interest
exist
companiesorgan
whose
product
servic
may
discuss
articl
role
sponsor
employe
astrazeneca
dr
gerhardsson
de
verdier
higenbottam
newbold
jenkin
mr
lewi
particip
studi
design
interpret
result
review
manuscript
dr
jenkin
conduct
statist
analys
provid
fi
rst
draft
figur
overal
conduct
studi
includ
design
respons
academ
investig
dr
mcivor
mr
johnston
addit
inform
eappendix
etabl
found
supplement
materi
area
onlin
articl
